Skip to main content
  • Home
  • Mark A. Munger

Mark A. Munger

Professor & Senior Associate Dean for College Affairs



  • 1986-1987 - Cardiovascular Pharmacology Research Fellowship, Case Western Reserve University and University Hospitals of Cleveland. Cleveland, Ohio
  • 1984-1986 - Doctor of Pharmacy, University of Illinois at Chicago, Chicago, Illinois
  • 1980-1983 - Bachelor of Science in Pharmacy, Oregon State University, Corvallis, Oregon


  • "Reduced risk of NSAID-induced adverse events with concomitant use of misoprostol (MICRO Study)"  4 th International Conference on Hypertension and Healthcare 2018, Keynote Speaker . Zurich, Switzerland, September, 2018
  • "An Optimal Community Pharmacy Service Delivery Model to Improve Healthcare in the Rural Community" Drs. Sundwall and Munger. Healthier Rural West 2019 Summit.  Salt Lake City, Utah. March, 2019
  • "Understanding Student Stress in Colleges of Pharmacy" 2019 AACP Annual Meeting, Chicago, Ill. July, 2019
  • "VTE Prevention Across the Continuum: Applications of Clinical Evidence for Extended Prophylaxis from Inpatient to Outpatient Care" Illinois Society of Health-System Pharmacists, Chicago, Illinois, September, 2018.
  • "Integrated Model of Primary Care Delivery: Medicine and Pharmacy Partnership to Improve Healthcare Outcomes" One Brave Idea Science Innovation Center, Brigham and Women’s Hospital, Harvard Medical School. Boston, MA, September, 2018   
  • "Understanding Student Stress in the Pharm.D. program." 2018 AACP Annual Meeting, Boston, MA July, 2018
  • "Assessing Pre-APPE Readiness: Three Different Models and Lessons Learned from the Field” 2018 AACP Annual Meeting. Boston, MA July, 2018
  • "Primary Care in Community Pharmacy. Is the Time Here?" National Association of Chain Drug Stores Deans Forum, Phoenix, AZ, May, 2017.
  • "Primary Care in Community Pharmacy. Is the Time Here?"  American Academy of Family Medicine, Kansas City, Missouri, February, 2017
  • "What Consumers Want from Pharmacists—Report of Survey Results."  Joint Commission of Pharmacy Practitioners, Washington D.C., November, 2016.
  • "Transformation of Community Pharmacy in the 21 st Century - a Research Journey: The OPTiPharm Study." Accreditation Council for Pharmacy Education, Chicago, Illinois, September, 2016.
  • "Transformation of Community Pharmacy in the 21 st Century - a Research Journey: The OPTiPharm Study." United States Center for Medicare and Medicaid Innovation, Washington D.C., USA Webinar Presentation, August, 2016.
  • "Transformation of Community Pharmacy in the 21 st Century - a Research Journey: The OPTiPharm Study." American Association of Colleges of Pharmacy (AACP) Leadership, Washington D.C., USA Webinar Presentation, April, 2016.


  • 2019-present: PHARMM 5121-   Drug-Drug Interactions 2 hours (60 students)
  • 2019-present: PHARM 6252-   Integrated Pharmacotherapeutics I Course-Master. (60 Students)
  • 2018-present: PHARM 7354-   Project Development Practicum Institutional Review Board 2 hours (60 Students)  
  • 2016-present: PHARM 6252- Integrated Pharmacotherapeutics I ADME Pharmacogenomics Module 1 hour (60 Students)
  • 2016-present: PHARM 5140- Foundation of Patient Centered Care Research Panel Discussion 1 hour (60 Students)
  • 2016-present: PHARM 6252- Integrated Pharmacotherapeutics I (CV Module Leader) Introduction, Hypertension, Stable Ischemic Heart Disease, Heart Failure, and Arrhythmia Therapeutics Total Oversight Hours: 24 hours; Direct Teaching: 10 hours (60 Students)
  • 2015-present: PHARM 5130- Foundation of Immunology/Pathology Hypersensitivity Reactions 1 hour (60 Students)
  • 2014-present: PHARM 5142- Foundations of Law, Ethics and Risk Mitigation Pharmacy Practice Updates and Risk Mitigation 2 hours (60 students)
  • 2014-present: NURS6021- Physical Assessment for Pharmacists. 5 hours (60 students) 

Positions Held

  • 2018- Present - Associate Dean, College Affairs , University of Utah College of Pharmacy
  • 2010-2018 - Director, Continuing Education, University of Utah College of Pharmacy
  • 2005-Present - Member, Utah Digital Health Services Commission (Appointment by Governor, State of Utah) (2010 Vice-Chairman)
  • 2004-Present - Adjunct Professor, Department of Internal Medicine, University of Utah School of Medicine
  • 2003-Present - Associate Dean, Academic Affairs, University of Utah College of Pharmacy
  • 2002-2004 - Chairman, Utah State Board of Pharmacy of the Division of Occupational and Professional Licensing
  • 1999-2007 - Member of Utah State Board of Pharmacy of the Division of Occupational and Professional Licensing
  • 1999-2005 - Chairman, University of Utah Institutional Review Board for Human Subject Protection
  • 2000-Present - Director, Clinical Pharmacology:  Utah Affiliated Hospitals (UTAH) Heart Failure Prevention and Treatment Program
  • 1998 - Professor of Pharmacy Practice, University of Utah

Publications & Other

    • Pulleyn T, Kim K, Witt DM, Feehan M, Munger MA, Understanding care barriers in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis 2019;
    • Parker T, Tak C, Feehan M, Munger MA. Consumer satisfaction and loyalty in community pharmacies: Analysis of a U.S. nationwide survey to identify driving factors J Am Coll Clin Pharm 2019;:(In Press)
    • Merrill, B, Tak C, Feehan M, Munger MA. Payers’ perspective on care provided in a community pharmacy setting. Annals of Pharmacother 2019; 2019 Mar 21:1060028019839440. doi: 10.1177/1060028019839440. [Epub ahead of print]  PMID:30895798
    • Tak C, Henchey C, Feehan M, Munger MA. Does Pharm.D. Does Pharm.D. Program stress and satisfaction drive professionalism in Pharm.D. Students?  Am J Pharm Edu 2019;Article ajpe7432. (posted online 03/27/2019)
    • Bress A, Dodson JA, King JB, Sauer B, Reese T, Radwanski P, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, Lafleur J. Clinical and economic outcomes of ranolazine versus conventional antianginals among Veterans with chronic stable angina. Am J Cardiol 2018; Sep 8. pii: S0002-9149(18)31726-0. doi: 10.1016/j.amjcard.2018.08.027. PMID: 30292334  
    • Feehan M, Walsh M, Van Ducker H, Godin J, Morrison M, Munger MA, Fleming R, Johnson SA, DeAngelis M, Witt DM. Prevalence and correlates of physical and emotional harms in a national US sample of patient with Venous Thromboembolism (VTE): a Structural Equation Model. Thromb Res 2018;172:181-87 PMID: 29843918
    • Munger MA, Walsh M, Godin J, Feehan M. Optimal primary care delivery in a community pharmacy: The OptiPHARM Study. Ann Pharmacother 2017;1-8. Doi: 10.1177/1060028017722795. PMID:28737045
    • Feehan M, Morrison MA, Tak C, Morisky D, DeAngelis M, Munger MA. Factors Predicting Self-Reported Medication Low Adherence in a Large Sample of Adults in the US General Population: a cross-sectional study. BMJ Open2017;7:e014435. Doi:10.1136/bmjopen-2016-04435. PMID: 28645958
    • King JP, Saniski-Nguyen A, Shah RU, Munger MA, Biskupiak J, Greene TH, Marrouche NF, Bress AP. A comparative effectiveness analysis of dobutamine versus milrinone in acute decompensated heart  failure out-of-hospital mortality.  Pharmacother 2017;May 5 doi: 10.1002/phar.1939. PMID: 28475215
    • Feehan M, Walsh M, Munger MA, Fleming J, Johnson SA, Witt DA. Emotional impact of venous thromboembolism (VTE): A qualitative analysis of patients’ journeys.  IP Patient Care Pharmacy and Clinics 2017;5:3. Link Here.
    • Feehan M, Walsh M, Godin J, Sundwall D, Munger MA. Patient preferences for Health Care Delivery through Community Pharmacy Setting in the USA: A Discrete Choice Study. J Clin Pharm Ther 2017:00:1-12 PMID:28627110
    • Feehan M,  Munger MA, Cooper DK,  Hess K, Durante R,  Jones GJ, Montuoro J,  Crandall AS, DeAngelis MM. Adherence to glaucoma medications Over 12 months in two US Community Pharmacy Chains. J Clin Med 2016;5:79-86 doi:10.3390/jcm5090079. PMID: 27618115
    • Feehan M, Durante R, Ruble J, Munger M. Qualitative interviews about pharmacists’ prescribing in the community setting. Am J HealthSys Pharm. 2016;73(18):1456-61. PMID: 27618115    
    • Munger MA, Durante R, Ranker L, Feehan M. I ntegration of community pharmacies into United States primary care delivery: A Qualitative Assessment.  IP Patient Care Pharmacy and Clinics 2016;4(4).
    • Munger MA, Sundwall M, Feehan, M. An integrated network of community pharmacy with family medicine. Am J Pharm Edu 2018;82(4):Article 6572 (Commissioned Commentary). PMID: 29867245 
    • 2018-present: Member, 2018-2019 American Association of Colleges of Pharmacy Academic Affairs Committee (AAC)
    • 2017-present: Member, Certificate in Competency in Heart Failure Task Force. Heart Failure Society of America
    • 2017-present: Member, Cannabinoid Product Advisory Board to Utah State Legislature (Appointed by Executive Director, State of Utah Department of Health)
    • 2016-present: Member, Healthcare Made Practical, LLC Pharmacy Learning Network Advisory Board
    • 2016-2018: Co-Chair, Heart Failure Society of America Recruitment Committee
    • 2016: ASHP Chapter Reviewer: "Drug-Induced Diseases. Prevention, Detection and Management" 3 rd Edition Chapter 24, Heart Failure
    • 2014-2017: Chairman, Controlled Substances Advisory Committee (Appointed by Executive Director, State of Utah Department of Health)
    • 1999-Present - National Association Boards of Pharmacy
    • 1997-Present - Hearth Failure Society of America
    • 1994-Present - New York Academy of Sciences
    • 1993-Present - American Society for Clinical Pharmacology and Therapeutics (Member)
    • 1991-Present - Utah Society of Hospital Pharmacists
    • 1990-Present - American Heart Association (Member, Council of Clinical Cardiology)
    • 1986-Present - American College of Clinical Pharmacy
    • 1982-Present - American Society of Hospital Pharmacists
    • 2011 - Visiting Scholar:  Loma Linda University, Riverside, California
    • 2011 - Visiting Scholar:  Idaho State University, Pocatello, Idaho
    • 2009 - Utah Society of Health-System Pharmacists Presidential Leadership Award
    • 2009 - American College of Clinical Pharmacy Cardiology Practice and Research Network Paper of the Year
    • 2009 - Nominated for United States Food and Drug Administration Cardio-Renal Panel
    • 2008 - Fellow, American College of Cardiology
    • 2008 - University of Illinois at Chicago College of Pharmacy Alumni of the Year
    • 2008-2010 - Utah Society of Health-Systems Pharmacists Association President
    • 2007 - Utah Society of Health-Systems Pharmacists President Elect
    • 2007 - American foundation for Pharmaceutical Education (AFPE) Clinical Pharmacy Post-Pharm.D. Fellowship in the Biomedical Research Sciences (Preceptor)